Investor Relations

LantheusProgenics
 

 

Corporate Profile

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“Lantheus”), which is a global leader in the development, distribution and commercialization of innovative diagnostic image agents and products. For 60 years, Lantheus has been dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. Our agents and products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging technologies.
 

As Progenics joined the Lantheus family, we added a pipeline of radiotherapeutics, targeted PET imaging agents and small molecule therapeutics in the oncology space.

Stock chart for: LNTH.O.
Data provided by Nasdaq. Minimum 15 minutes delayed.